Back
ProShares UltraShort 20+ Year Treasury Vs. Ultragenyx Pharmaceutical Industry Stock Comparison
Sell
44
TBT
ProShares UltraShort 20+ Year Treasury
Last Price:
33.18
Seasonality Move:
-5.03%
Sell
44
RARE
Ultragenyx Pharmaceutical
Last Price:
41.49
Seasonality Move:
-0.9%
Sell
44
ProShares UltraShort 20+ Year Treasury (TBT)
is a Sell
Is ProShares UltraShort 20+ Year Treasury a Buy, Sell or Hold?
- The current ProShares UltraShort 20+ Year Treasury [TBT] share price is $33.50. The Score for TBT is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
- TBT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
44
Ultragenyx Pharmaceutical (RARE)
is a Sell
Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?
- The current Ultragenyx Pharmaceutical [RARE] share price is $40.50. The Score for RARE is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
- RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
TBT Stock Price Chart
What is ProShares UltraShort 20+ Year Treasury's stock price today?
-
The ProShares UltraShort 20+ Year Treasury share price today is $33.50
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and TBT is experiencing buying pressure, which is a positive indicator for future bullish movement.
RARE Stock Price Chart
What is Ultragenyx Pharmaceutical's stock price today?
-
The Ultragenyx Pharmaceutical share price today is $40.50
The current trend is relatively stagnant and RARE is experiencing slight buying pressure.
TBT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.65 | Sell |
| Relative Strength Index (14 RSI): | 43.65 | Sell |
| Chaikin Money Flow: | 254048 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (33.25 - 35.79) | Sell |
| Bollinger Bands (100): | (33.2 - 36.32) | Sell |
RARE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.6 | Sell |
| Relative Strength Index (14 RSI): | 49.22 | Sell |
| Chaikin Money Flow: | 494801 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (38.79 - 41.97) | Buy |
| Bollinger Bands (100): | (40.81 - 48.79) | Sell |
TBT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 33.2 | Buy |
| 20-day SMA: | 34.27 | Sell |
| 50-day SMA: | 35.57 | Sell |
| 200-day SMA: | 35.51 | Sell |
| 8-day EMA: | 33.42 | Buy |
| 20-day EMA: | 34.04 | Sell |
| 50-day EMA: | 34.73 | Sell |
| 200-day EMA: | 34.4 | Sell |
RARE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 39.2 | Buy |
| 20-day SMA: | 40.42 | Buy |
| 50-day SMA: | 41.53 | Sell |
| 200-day SMA: | 42.45 | Sell |
| 8-day EMA: | 39.89 | Buy |
| 20-day EMA: | 40.39 | Buy |
| 50-day EMA: | 41.79 | Sell |
| 200-day EMA: | 43.35 | Sell |
ProShares UltraShort 20+ Year Treasury Earnings Growth & TBT Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.51 per share, an increase next quarter of $0.03 per share, an increase this year of $0.94 per share, and an increase next year of $1.06 per share.
ProShares UltraShort 20+ Year Treasury Technical Analysis
| Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 12 | 13 | 14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Ultragenyx Pharmaceutical Technical Analysis
| Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 12 | 13 | 14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||